Elite Pharmaceuticals, Inc. (ELTP)
0.288
0.00 (0.00%)
USD |
OTCM |
Aug 27, 16:00
Elite Pharmaceuticals Cash from Operations (Quarterly) : 10.07M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.07M |
| March 31, 2026 | 9.146M |
| December 31, 2025 | -5.278M |
| September 30, 2025 | 5.104M |
| June 30, 2025 | 14.78M |
| March 31, 2025 | 3.918M |
| December 31, 2024 | -1.064M |
| September 30, 2024 | 1.457M |
| June 30, 2024 | 3.144M |
| March 31, 2024 | 2.06M |
| December 31, 2023 | -2.396M |
| September 30, 2023 | -0.2359M |
| June 30, 2023 | -2.710M |
| March 31, 2023 | 2.969M |
| December 31, 2022 | -0.5679M |
| September 30, 2022 | 1.495M |
| June 30, 2022 | -0.5575M |
| March 31, 2022 | 1.605M |
| December 31, 2021 | 3.034M |
| September 30, 2021 | 0.1538M |
| June 30, 2021 | 1.716M |
| March 31, 2021 | -0.7494M |
| December 31, 2020 | 1.235M |
| September 30, 2020 | 1.900M |
| June 30, 2020 | 0.8074M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.206M |
| December 31, 2019 | -0.3122M |
| September 30, 2019 | -0.4638M |
| June 30, 2019 | 0.1883M |
| March 31, 2019 | -2.136M |
| December 31, 2018 | -1.268M |
| September 30, 2018 | -1.679M |
| June 30, 2018 | -1.710M |
| March 31, 2018 | -1.014M |
| December 31, 2017 | -0.4781M |
| September 30, 2017 | -2.226M |
| June 30, 2017 | -1.091M |
| March 31, 2017 | -4.076M |
| December 31, 2016 | -0.7264M |
| September 30, 2016 | -2.317M |
| June 30, 2016 | -0.7642M |
| March 31, 2016 | 0.6064M |
| December 31, 2015 | -1.784M |
| September 30, 2015 | -3.479M |
| June 30, 2015 | 1.891M |
| March 31, 2015 | -3.856M |
| December 31, 2014 | -2.606M |
| September 30, 2014 | -4.428M |
| June 30, 2014 | -4.213M |
| March 31, 2014 | -1.420M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Nektar Therapeutics | -75.77M |
| Daré Bioscience, Inc. | -6.775M |
| Eton Pharmaceuticals, Inc. | 7.255M |
| ANI Pharmaceuticals, Inc. | 56.67M |
| Corcept Therapeutics, Inc. | 33.54M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.809M |
| Cash from Financing (Quarterly) | -0.1146M |
| Free Cash Flow | 17.53M |
| Free Cash Flow Per Share (Quarterly) | 0.0082 |
| Free Cash Flow to Equity (Quarterly) | 9.504M |
| Free Cash Flow to Firm (Quarterly) | 9.317M |
| Free Cash Flow Yield | 5.42% |